Simone Brandt
Papers
1
Total Citations
5
H-Index
1
About
Simone Brandt is a pioneering urologic surgeon and clinical researcher whose work is fundamentally reshaping the surgical management of bladder cancer. Her primary research focus lies in optimizing robot-assisted radical cystectomy (RARC) and urinary diversion techniques to reduce severe postoperative complications. Brandt’s most significant contribution is her leadership of the MOSAIC randomized controlled trial, which introduced the retrosigmoid ileal conduit as a novel method to lower the rate of benign ureteroenteric strictures—a debilitating complication affecting up to 15% of patients. Her landmark 2024 publication, “DaBlaCa-16,” demonstrated the feasibility of this approach and its potential to dramatically improve patient outcomes. With over 5 citations in its first year, this work is rapidly becoming a cornerstone in the field. Brandt’s research is characterized by rigorous, evidence-based innovation, directly translating surgical hypotheses into clinical practice. She is a leading voice in the DaBlaCa research network, championing randomized trials that challenge conventional wisdom. For students and researchers, Brandt exemplifies how a focused, high-impact clinical trial can address a critical unmet need, offering a blueprint for reducing morbidity in major oncologic surgery.
Research Focus
Key Achievements
Top Papers
- 1